Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Adam

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Communications Medicine|April 17, 2023
The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trialsKristian Thorlund, Davey Smith, Christopher Linsell, et al.
The Lancet. Oncology|October 30, 2020
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocolMary W Redman, Vassiliki A Papadimitrakopoulou, Katherine Minichiello, et al.
Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Communications Medicine|April 17, 2023
The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trialsKristian Thorlund, Davey Smith, Christopher Linsell, et al.
The Lancet. Oncology|October 30, 2020
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocolMary W Redman, Vassiliki A Papadimitrakopoulou, Katherine Minichiello, et al.
Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.
Pageof 1